These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
376 related items for PubMed ID: 26950211
1. Hormesis in Cholestatic Liver Disease; Preconditioning with Low Bile Acid Concentrations Protects against Bile Acid-Induced Toxicity. Verhaag EM, Buist-Homan M, Koehorst M, Groen AK, Moshage H, Faber KN. PLoS One; 2016; 11(3):e0149782. PubMed ID: 26950211 [Abstract] [Full Text] [Related]
2. Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition-associated cholestasis in mice. El Kasmi KC, Ghosh S, Anderson AL, Devereaux MW, Balasubramaniyan N, D'Alessandro A, Orlicky DJ, Suchy FJ, Shearn CT, Sokol RJ. Hepatology; 2022 Feb; 75(2):252-265. PubMed ID: 34387888 [Abstract] [Full Text] [Related]
3. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor. Li T, Xu L, Zheng R, Wang X, Li L, Ji H, Hu Q. Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210 [Abstract] [Full Text] [Related]
4. Sphingosine kinase-1 inhibition protects primary rat hepatocytes against bile salt-induced apoptosis. Karimian G, Buist-Homan M, Schmidt M, Tietge UJ, de Boer JF, Klappe K, Kok JW, Combettes L, Tordjmann T, Faber KN, Moshage H. Biochim Biophys Acta; 2013 Dec; 1832(12):1922-9. PubMed ID: 23816565 [Abstract] [Full Text] [Related]
5. Bile acid-induced tissue factor activity in hepatocytes correlates with activation of farnesoid X receptor. Greimel T, Jahnel J, Pohl S, Strini T, Tischitz M, Meier-Allard N, Holasek S, Meinel K, Aguiriano-Moser V, Zobel J, Haidl H, Gallistl S, Panzitt K, Wagner M, Schlagenhauf A. Lab Invest; 2021 Oct; 101(10):1394-1402. PubMed ID: 34145381 [Abstract] [Full Text] [Related]
6. Tauro-β-muricholic acid restricts bile acid-induced hepatocellular apoptosis by preserving the mitochondrial membrane potential. Denk GU, Kleiss CP, Wimmer R, Vennegeerts T, Reiter FP, Schulz S, Zischka H, Rust C. Biochem Biophys Res Commun; 2012 Aug 10; 424(4):758-64. PubMed ID: 22809502 [Abstract] [Full Text] [Related]
7. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition. Vaquero J, Monte MJ, Dominguez M, Muntané J, Marin JJ. Biochem Pharmacol; 2013 Oct 01; 86(7):926-39. PubMed ID: 23928191 [Abstract] [Full Text] [Related]
8. Pertussis toxin, an inhibitor of G(αi) PCR, inhibits bile acid- and cytokine-induced apoptosis in primary rat hepatocytes. Karimian G, Buist-Homan M, Faber KN, Moshage H. PLoS One; 2012 Oct 01; 7(8):e43156. PubMed ID: 22900098 [Abstract] [Full Text] [Related]
9. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity. Yu J, Lo JL, Huang L, Zhao A, Metzger E, Adams A, Meinke PT, Wright SD, Cui J. J Biol Chem; 2002 Aug 30; 277(35):31441-7. PubMed ID: 12052824 [Abstract] [Full Text] [Related]
10. Angiotensin II protects primary rat hepatocytes against bile salt-induced apoptosis. Karimian G, Buist-Homan M, Mikus B, Henning RH, Faber KN, Moshage H. PLoS One; 2012 Aug 30; 7(12):e52647. PubMed ID: 23300732 [Abstract] [Full Text] [Related]
11. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. Liu Y, Binz J, Numerick MJ, Dennis S, Luo G, Desai B, MacKenzie KI, Mansfield TA, Kliewer SA, Goodwin B, Jones SA. J Clin Invest; 2003 Dec 30; 112(11):1678-87. PubMed ID: 14623915 [Abstract] [Full Text] [Related]
12. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. Schoemaker MH, Gommans WM, Conde de la Rosa L, Homan M, Klok P, Trautwein C, van Goor H, Poelstra K, Haisma HJ, Jansen PL, Moshage H. J Hepatol; 2003 Aug 30; 39(2):153-61. PubMed ID: 12873810 [Abstract] [Full Text] [Related]
13. Dehydrodiconiferyl alcohol, a lignan from Herpetospermum pedunculosum, alleviates cholestasis by activating pathways associated with the farnesoid X receptor. Wei X, Ma Y, Dong Z, Wang G, Lan X, Liao Z, Chen M. Phytomedicine; 2021 Jan 30; 80():153378. PubMed ID: 33113499 [Abstract] [Full Text] [Related]
14. Metabolic preconditioning protects BSEP/ABCB11-/- mice against cholestatic liver injury. Fuchs CD, Paumgartner G, Wahlström A, Schwabl P, Reiberger T, Leditznig N, Stojakovic T, Rohr-Udilova N, Chiba P, Marschall HU, Trauner M. J Hepatol; 2017 Jan 30; 66(1):95-101. PubMed ID: 27593105 [Abstract] [Full Text] [Related]
15. Protective effects of yangonin from an edible botanical Kava against lithocholic acid-induced cholestasis and hepatotoxicity. Kong Y, Gao X, Wang C, Ning C, Liu K, Liu Z, Sun H, Ma X, Sun P, Meng Q. Eur J Pharmacol; 2018 Apr 05; 824():64-71. PubMed ID: 29427579 [Abstract] [Full Text] [Related]
16. The active metabolite of leflunomide, A77 1726, protects rat hepatocytes against bile acid-induced apoptosis. Vrenken TE, Buist-Homan M, Kalsbeek AJ, Faber KN, Moshage H. J Hepatol; 2008 Nov 05; 49(5):799-809. PubMed ID: 18809221 [Abstract] [Full Text] [Related]
17. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro. Gao X, Fu T, Wang C, Ning C, Liu K, Liu Z, Sun H, Ma X, Huo X, Yang X, Zou M, Meng Q. Toxicol Appl Pharmacol; 2018 Jun 01; 348():105-116. PubMed ID: 29660435 [Abstract] [Full Text] [Related]
18. Bile salt excretory pump: biology and pathobiology. Suchy FJ, Ananthanarayanan M. J Pediatr Gastroenterol Nutr; 2006 Jul 01; 43 Suppl 1():S10-6. PubMed ID: 16819395 [Abstract] [Full Text] [Related]
19. Scopoletin and umbelliferone protect hepatocytes against palmitate- and bile acid-induced cell death by reducing endoplasmic reticulum stress and oxidative stress. Wu Z, Geng Y, Buist-Homan M, Moshage H. Toxicol Appl Pharmacol; 2022 Feb 01; 436():115858. PubMed ID: 34979142 [Abstract] [Full Text] [Related]
20. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Pineda Torra I, Claudel T, Duval C, Kosykh V, Fruchart JC, Staels B. Mol Endocrinol; 2003 Feb 01; 17(2):259-72. PubMed ID: 12554753 [Abstract] [Full Text] [Related] Page: [Next] [New Search]